Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids

Deborah L. Doxey, Salvador Nares, Bina Park, Chi Trieu, Christopher W. Cutler, Anthony M. Iacopino

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Diabetes (type I and type II) affects approximately 13 million people in the United States. Delayed and incomplete healing of wounds can be a major problem for diabetic patients. Macrophages are an important cell in the complex process of wound repair representing the major source of cytokines throughout the wound healing process. Cytokines mediate many of the cellular responses critical to timely wound repair. It has been suggested that diabetes impairs wound healing through disruption of local cytokine production. We previously demonstrated that platelet-derived growth factor B chain (PDGF-B) levels are deficient at the wound site of diabetic rats. In the present study, we measured the levels of several marker cytokines released from cultured peritoneal macrophages of diabetic, nondiabetic hyperlipidemic, and normal rats. The diabetic condition was associated with a generalized reduction of macrophage cytokine release. Nondiabetic hyperlipidemic animals demonstrated similar cytokine reduction supporting the hypothesis that elevated serum lipids are the primary determinants of diabetes-induced reductions in macrophage cytokine release. Thus, manipulation of serum lipids may be a therapeutically useful modality for controlling macrophage cytokine release in the inflammatory and/or wound environment.

Original languageEnglish (US)
Pages (from-to)1127-1136
Number of pages10
JournalLife sciences
Volume63
Issue number13
DOIs
StatePublished - Aug 21 1998

Fingerprint

Macrophages
Medical problems
Rats
Cytokines
Lipids
Serum
Wound Healing
Wounds and Injuries
Repair
Proto-Oncogene Proteins c-sis
Peritoneal Macrophages
Type 1 Diabetes Mellitus
Animals

Keywords

  • Cytokines
  • Diabetes
  • Fenofibrate
  • Hyperlipidemia
  • Macrophage
  • Rat model

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Diabetes-induced impairment of macrophage cytokine release in a rat model : Potential role of serum lipids. / Doxey, Deborah L.; Nares, Salvador; Park, Bina; Trieu, Chi; Cutler, Christopher W.; Iacopino, Anthony M.

In: Life sciences, Vol. 63, No. 13, 21.08.1998, p. 1127-1136.

Research output: Contribution to journalArticle

Doxey, Deborah L. ; Nares, Salvador ; Park, Bina ; Trieu, Chi ; Cutler, Christopher W. ; Iacopino, Anthony M. / Diabetes-induced impairment of macrophage cytokine release in a rat model : Potential role of serum lipids. In: Life sciences. 1998 ; Vol. 63, No. 13. pp. 1127-1136.
@article{569bb5c22db545d4acbcf808e3eb68b3,
title = "Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids",
abstract = "Diabetes (type I and type II) affects approximately 13 million people in the United States. Delayed and incomplete healing of wounds can be a major problem for diabetic patients. Macrophages are an important cell in the complex process of wound repair representing the major source of cytokines throughout the wound healing process. Cytokines mediate many of the cellular responses critical to timely wound repair. It has been suggested that diabetes impairs wound healing through disruption of local cytokine production. We previously demonstrated that platelet-derived growth factor B chain (PDGF-B) levels are deficient at the wound site of diabetic rats. In the present study, we measured the levels of several marker cytokines released from cultured peritoneal macrophages of diabetic, nondiabetic hyperlipidemic, and normal rats. The diabetic condition was associated with a generalized reduction of macrophage cytokine release. Nondiabetic hyperlipidemic animals demonstrated similar cytokine reduction supporting the hypothesis that elevated serum lipids are the primary determinants of diabetes-induced reductions in macrophage cytokine release. Thus, manipulation of serum lipids may be a therapeutically useful modality for controlling macrophage cytokine release in the inflammatory and/or wound environment.",
keywords = "Cytokines, Diabetes, Fenofibrate, Hyperlipidemia, Macrophage, Rat model",
author = "Doxey, {Deborah L.} and Salvador Nares and Bina Park and Chi Trieu and Cutler, {Christopher W.} and Iacopino, {Anthony M.}",
year = "1998",
month = "8",
day = "21",
doi = "10.1016/S0024-3205(98)00374-9",
language = "English (US)",
volume = "63",
pages = "1127--1136",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Diabetes-induced impairment of macrophage cytokine release in a rat model

T2 - Potential role of serum lipids

AU - Doxey, Deborah L.

AU - Nares, Salvador

AU - Park, Bina

AU - Trieu, Chi

AU - Cutler, Christopher W.

AU - Iacopino, Anthony M.

PY - 1998/8/21

Y1 - 1998/8/21

N2 - Diabetes (type I and type II) affects approximately 13 million people in the United States. Delayed and incomplete healing of wounds can be a major problem for diabetic patients. Macrophages are an important cell in the complex process of wound repair representing the major source of cytokines throughout the wound healing process. Cytokines mediate many of the cellular responses critical to timely wound repair. It has been suggested that diabetes impairs wound healing through disruption of local cytokine production. We previously demonstrated that platelet-derived growth factor B chain (PDGF-B) levels are deficient at the wound site of diabetic rats. In the present study, we measured the levels of several marker cytokines released from cultured peritoneal macrophages of diabetic, nondiabetic hyperlipidemic, and normal rats. The diabetic condition was associated with a generalized reduction of macrophage cytokine release. Nondiabetic hyperlipidemic animals demonstrated similar cytokine reduction supporting the hypothesis that elevated serum lipids are the primary determinants of diabetes-induced reductions in macrophage cytokine release. Thus, manipulation of serum lipids may be a therapeutically useful modality for controlling macrophage cytokine release in the inflammatory and/or wound environment.

AB - Diabetes (type I and type II) affects approximately 13 million people in the United States. Delayed and incomplete healing of wounds can be a major problem for diabetic patients. Macrophages are an important cell in the complex process of wound repair representing the major source of cytokines throughout the wound healing process. Cytokines mediate many of the cellular responses critical to timely wound repair. It has been suggested that diabetes impairs wound healing through disruption of local cytokine production. We previously demonstrated that platelet-derived growth factor B chain (PDGF-B) levels are deficient at the wound site of diabetic rats. In the present study, we measured the levels of several marker cytokines released from cultured peritoneal macrophages of diabetic, nondiabetic hyperlipidemic, and normal rats. The diabetic condition was associated with a generalized reduction of macrophage cytokine release. Nondiabetic hyperlipidemic animals demonstrated similar cytokine reduction supporting the hypothesis that elevated serum lipids are the primary determinants of diabetes-induced reductions in macrophage cytokine release. Thus, manipulation of serum lipids may be a therapeutically useful modality for controlling macrophage cytokine release in the inflammatory and/or wound environment.

KW - Cytokines

KW - Diabetes

KW - Fenofibrate

KW - Hyperlipidemia

KW - Macrophage

KW - Rat model

UR - http://www.scopus.com/inward/record.url?scp=0032555325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032555325&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(98)00374-9

DO - 10.1016/S0024-3205(98)00374-9

M3 - Article

C2 - 9763208

AN - SCOPUS:0032555325

VL - 63

SP - 1127

EP - 1136

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 13

ER -